Neonatal Phototherapy Devices Market to Reach US$ 147.9 Mn by 2032, Driven by Rising Infant Care Needs, Persistence Market Research

Market Overview and Growth Insights

The global neonatal phototherapy devices market is witnessing notable growth due to the rising incidence of neonatal jaundice, especially among premature and low birth weight infants. According to the latest report by Persistence Market Research, the market is projected to grow from US$ 110.4 Mn in 2025 to US$ 147.9 Mn by 2032, registering a CAGR of 4.3% during the forecast period. This growth is primarily fueled by the increasing need for effective phototherapy solutions that help prevent complications such as kernicterus and long-term neurodevelopmental disorders.

Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/35192

Among product segments, phototherapy lamps are anticipated to lead the market, contributing around 48.6% of the total revenue in 2025, owing to their high intensity and widespread use in hospitals and NICUs. Regionally, North America is expected to hold the largest share at 40.2%, driven by the region's strong neonatal care infrastructure, early technology adoption, and high awareness among healthcare providers and parents. Furthermore, growing support from governments and non-governmental organizations in emerging economies like India and Brazil is also encouraging the deployment of affordable, portable, and non-invasive devices.

✦ Key Highlights from the Report:

✦ North America will account for 40.2% of the market in 2025 due to advanced neonatal care infrastructure.
✦ Phototherapy lamps will dominate the product segment with a 48.6% share in 2025.
✦ Neonatal jaundice management will hold 83.2% of the application segment in 2025.
✦ Portable and home-use phototherapy devices are gaining traction in low-resource settings.
✦ LED-based devices are expected to account for 62.1% share due to their energy efficiency.
✦ The market is shifting toward AI-integrated and wearable phototherapy technologies.

Market Segmentation

The neonatal phototherapy devices market is broadly segmented based on product type, light source, and application.

Phototherapy lamps continue to be the most preferred type due to their proven effectiveness in hospital and NICU settings. These include fluorescent and LED variants. Fluorescent lamps, though economical, are being replaced by LED-based systems such as GE's Lullaby LED and Natus neoBLUE, which offer better intensity control, reduced heat output, and energy efficiency.

In terms of light source, LED technology is gaining traction and is projected to hold over 62% of the market share by 2025. LEDs are favored for their longer lifespan, lower maintenance needs, and ability to emit high-intensity blue light for efficient bilirubin breakdown.

When it comes to application, neonatal jaundice management remains the dominant area of focus, accounting for 83.2% of market demand. This segment's growth is attributed to the high global prevalence of neonatal jaundice, which affects over 60% of full-term and nearly 80% of preterm newborns. In contrast, emerging applications such as treating infantile skin conditions using phototherapy are expected to grow gradually as research expands in this area.

Regional Insights and Trends

North America
North America is set to remain the dominant region, capturing over 40% of the global market by 2025. The region's strength lies in its well-established neonatal care ecosystem, supported by leading players like NeoLight and GE Healthcare. Innovative collaborations, such as NeoLight's partnership with ANT Neuro and the development of non-nutritive sucking technology with Florida State University, are paving the way for next-gen neonatal care solutions. The region also benefits from early adoption of hybrid incubator-phototherapy units and favorable reimbursement frameworks.

East Asia
East Asia is a fast-growing market, projected to secure around 18.3% market share by 2025. The expansion is supported by healthcare digitization, improved access to neonatal care, and rising birth rates. Japan, for instance, is making strides with wearable jaundice monitors, which allow continuous bilirubin tracking. GE Healthcare's expansion of its digital commerce platform in countries like Thailand, Malaysia, and the Philippines has further improved access to affordable phototherapy devices. These regional trends highlight East Asia's emergence as an innovation and accessibility hub in neonatal healthcare.

Market Drivers

The primary driver for market growth is the increasing rate of premature births and associated complications such as neonatal jaundice. Preterm infants have underdeveloped livers and are more susceptible to hyperbilirubinemia. The need for safe, effective, and non-invasive treatment solutions has led to the widespread use of advanced LED phototherapy systems.

Technological innovations, including the integration of AI for real-time bilirubin monitoring and smart wearables, are also propelling market growth. Devices such as Atom Medical's Dual Incu i and Brilliance Pro by D-Rev offer a combination of temperature regulation and light therapy, enhancing clinical efficiency. Additionally, rising healthcare investments, favorable regulatory guidelines, and increased training for NICU staff contribute to the growing demand for phototherapy devices.

Market Restraints

Despite robust growth drivers, the market faces significant restraints, especially in low-resource regions. Limited healthcare infrastructure, scarcity of trained professionals, and insufficient NICU setups restrict access to timely and effective neonatal care. In rural areas of Africa, South Asia, and Latin America, many infants still suffer from untreated jaundice due to lack of awareness and medical facilities.

Moreover, phototherapy equipment requires a stable power supply and maintenance, both of which are challenging in remote regions. The absence of government funding or donor support in certain regions further hampers the adoption of advanced treatment systems.

Market Opportunities

There is a significant opportunity for governments and NGOs to improve neonatal healthcare infrastructure through targeted investment and partnerships. Programs like India's National Health Mission (NHM) and Brazil's Rede Cegonha are prime examples of how policy-driven initiatives can expand NICU availability and improve newborn survival rates. These programs are also boosting demand for high-performance phototherapy devices.

Furthermore, as the trend shifts toward home-based care, manufacturers have an opportunity to design compact, portable, and user-friendly phototherapy units. The integration of AI and mobile health apps can further enhance patient monitoring, reduce hospital stay durations, and provide cost-effective treatment alternatives, particularly in underserved regions.

# Frequently Asked Questions (FAQs):

How big is the Neonatal Phototherapy Devices Market in 2025?
What is the projected growth rate of the neonatal phototherapy devices market by 2032?
Who are the key players in the global market for neonatal phototherapy devices?
What is the market forecast for neonatal phototherapy devices through 2032?
Which region is estimated to dominate the industry through the forecast period?

Company Insights

• GE Healthcare
• Philips Healthcare
• Natus Medical Incorporated
• NeoLight LLC
• Atom Medical Corporation
• Draegerwerk AG & Co. KGaA
• D-Rev (now Equalize Health)
• AVI Healthcare Pvt. Ltd.
• Ibis Medical Equipment & Systems Pvt. Ltd.
• Phoenix Medical Systems Pvt. Ltd.

Recent Developments:

• In 2024, NeoLight partnered with Florida State University to co-develop advanced neonatal neurodevelopmental technologies, expanding its product portfolio.
• GE Healthcare launched an upgraded version of its Lullaby LED Phototherapy System in select Asia Pacific markets, enhancing device efficiency and portability.

Conclusion

The neonatal phototherapy devices market is on a steady growth path, driven by the increasing prevalence of neonatal jaundice and advancements in phototherapy technology. With a projected market size of US$ 147.9 Mn by 2032, the demand for safer, more efficient, and accessible devices is intensifying globally. As regions like North America and East Asia lead the way with innovation and adoption, developing countries are catching up through public health initiatives and infrastructure investments. The shift toward portable, wearable, and AI-enabled phototherapy systems represents the future of neonatal care, offering hope for better health outcomes and lower infant mortality rates worldwide.

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web:
https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.